Suppr超能文献

变应性鼻炎患者求医模式调查

Survey on Treatment-Seeking Patterns in Patients With Allergic Rhinitis.

作者信息

Ryu Gwanghui, Kim Do Hyun, Jeong Chang Yeong, Lee Sang Min, Lee Il Hwan, Kim Soo Whan, Yang Hyeon-Jong, Kim Mi-Ae, Kim Dong-Kyu

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Department of Otolaryngology-Head and Neck Surgery, Seoul Saint Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

J Rhinol. 2024 Nov;31(3):138-144. doi: 10.18787/jr.2024.00023. Epub 2024 Nov 30.

Abstract

BACKGROUND AND OBJECTIVES

The medications preferred by patients for allergic rhinitis and their usage remain unclear. This study investigated treatment-seeking behaviors in patients with allergic rhinitis, including medical treatments, environmental controls, and surgical treatments.

METHODS

In this study, a cross-sectional survey was conducted by internal medicine, pediatric, or otorhinolaryngology physicians at university hospitals from January 2022 to April 2022. A questionnaire was administered to patients with confirmed allergic rhinitis to collect information regarding medical treatments (prescription and over-the-counter medication use patterns, comorbid asthma, and allergen-specific immunotherapy), environmental controls (usage of air purifiers and pet avoidance), and experiences with surgical treatments.

RESULTS

We included 51 patients with allergic rhinitis with a mean age of 31.6±16.0 years. Among them, 47 (92.2%) and 6 (11.8%) patients had pollen allergies and asthma, respectively. Furthermore, 41 (80.4%) patients took prescribed medicines, while 39 (76.5%) patients only used the medication when experiencing symptoms. Thirty patients (58.8%) reported concurrent use of intranasal sprays and oral medications. Thirty-three patients (64.7%) reported awareness of immunotherapy, and there were no preferential differences between subcutaneous (52%) and sublingual immunotherapy (48%). Of the 36 patients (70.6%) who reported using an air purifier, 38.9% considered it helpful in preventing allergic rhinitis symptoms. Fourteen patients (27.5%) currently or previously had a companion animal, with half experiencing worsening of symptoms. Twelve patients had received surgical treatment and reported high satisfaction levels (41.6%, very satisfied; 41.6%, satisfied).

CONCLUSION

Patients with allergic rhinitis showed similar preferences for oral and spray medications. They also showed satisfaction with surgical treatments and an interest in the environmental management of allergic rhinitis.

摘要

背景与目的

患者治疗过敏性鼻炎时首选的药物及其使用情况尚不清楚。本研究调查了过敏性鼻炎患者的求医行为,包括药物治疗、环境控制和手术治疗。

方法

本研究于2022年1月至2022年4月期间,由大学医院的内科、儿科或耳鼻喉科医生进行横断面调查。对确诊为过敏性鼻炎的患者进行问卷调查,以收集有关药物治疗(处方药和非处方药使用模式、合并哮喘和过敏原特异性免疫治疗)、环境控制(空气净化器的使用和避免接触宠物)以及手术治疗经历的信息。

结果

我们纳入了51例过敏性鼻炎患者,平均年龄为31.6±16.0岁。其中,分别有47例(92.2%)和6例(11.8%)患者对花粉过敏和患有哮喘。此外,41例(80.4%)患者服用处方药,而39例(76.5%)患者仅在出现症状时使用药物。30例(58.8%)患者报告同时使用鼻喷雾剂和口服药物。33例(64.7%)患者报告了解免疫治疗,皮下免疫治疗(52%)和舌下免疫治疗(48%)之间无优先差异。在报告使用空气净化器的36例(70.6%)患者中,38.9%的患者认为其有助于预防过敏性鼻炎症状。14例(27.5%)患者目前或以前养过宠物,其中一半患者症状加重。12例患者接受过手术治疗,报告的满意度较高(41.6%,非常满意;41.6%,满意)。

结论

过敏性鼻炎患者对口服药物和喷雾剂的偏好相似。他们对手术治疗也表示满意,并对过敏性鼻炎的环境管理感兴趣。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4da/11685916/f571d5a6c70f/jr-2024-00023f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验